Preventing cancer, cardiovascular disease, and diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association

Ca-A Cancer Journal for Clinicians

Volumn 54, Issue 4, 2004, Pages 190-207

  Eyre, Harmon ^a   Kahn, Richard ^b   Robertson, Rose Marie ^c   Clark, Nathaniel G ^b   Doyle, Colleen ^a   Gansler, Ted ^a   Glynn, Thomas ^a   Hong, Yuling ^c   Smith, Robert A ^a   Taubert, Kathryn ^c   Thun, Michael J ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b AMERICAN DIABETES ASSOCIATION   (United States)

^c AMERICAN HEART ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GLUCOSE; METFORMIN; PROSTATE SPECIFIC ANTIGEN;

AGED; AWARENESS; BARIUM ENEMA; BREAST CANCER; BREAST EXAMINATION; CANCER SCREENING; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; COLONOSCOPY; COLORECTAL CANCER; CONSULTATION; COOPERATION; COST CONTROL; DEATH; DIET RESTRICTION; DIETARY INTAKE; DYSLIPIDEMIA; EARLY DIAGNOSIS; EXERCISE; FEEDING BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; HYPERTENSION; IMMOBILIZATION; INCIDENCE; LAW; LIFESTYLE; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; MEDICAL RESEARCH; MEDICAL SOCIETY; MORTALITY; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OCCULT BLOOD TEST; ORAL GLUCOSE TOLERANCE TEST; PATIENT COMPLIANCE; PERIODIC MEDICAL EXAMINATION; PHYSICAL ACTIVITY; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTATE CANCER; PUBLIC HEALTH SERVICE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SIGMOIDOSCOPY; SMOKING CESSATION; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WEIGHT REDUCTION;

EID: 4344692338     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.54.4.190     Document Type: Review

References (145)

1. Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep 2003;52:1-85.
2. Centers for Disease Control and Prevention, National Center for Health Statistics. Effectiveness in disease and injury prevention - estimated national spending on prevention - United States, 1988. MMWR Morb Mortal Wkly Rep 1992; 41:529-531.
3. National Center for Health Statistics. Health, United States, 2003 with Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics; 2003.
4. US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington, DC: US Government Printing Office, 2000.
5. US Preventive Services Task Force. Guide to Clinical Preventive Services, Third Edition: Periodic Updates. Rockville, MD: Agency for Healthcare Research and Quality; 2004. AHRQ Publication No. 04-IP003.
6. Centers for Disease Control and Prevention. Guide to Community Preventive Services. Vol. 24. Atlanta, GA: Centers for Disease Control and Prevention; 2004.
7. National Committee for Quality Assurance. The Health Plan Employer Data and Information Set (HEDIS). Washington, DC: National Committee for Quality Assurance; 2004.
8. Smith RA, Wender RC. Cancer screening and the periodic health examination. Cancer 2004;100:1553-1557.
9. Minino A, Arias E, Kochanek KD, et al. Deaths: Final Data for 2000. Hyattsville, MD: National Center for Health Statistics; 2002. National vital statistics reports; vol. 50 no. 15.
10. American Heart Association. Heart Disease and Stroke Statistics - 2004 Update. Dallas, TX: American Heart Association; 2004.
11. Ries L, Eisner M, Kosary C, et al. (eds). SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003.
12. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
13. Ayanian JZ, Zaslavsky AM, Weissman JS, et al. Undiagnosed hypertension and hypercholesterolemia among uninsured and insured adults in the Third National Health and Nutrition Examination Survey. Am J Public Health 2003;93: 2051-2054.
14. American Heart Association. Heart Disease and Stroke Statistics - 2003 Update. Dallas, TX: American Heart Association; 2003.
15. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003. Rev ed. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2004.
16. Centers for Disease Control and Prevention. Prevalence of diabetes and impaired fasting glucose in adults-United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2003;52: 833-837.
17. National Heart, Lung, and Blood Institute. NHLBI Year 2003 Fact Book. Bethesda, MD: National Institutes of Health; 2003.
18. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-932.
19. National Institutes of Health. Fact Book, Fiscal Year 2002. Bethesda, MD: National Institutes of Health; 2003.
20. Eastman RC, Javitt JC, Herman WH, et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care 1997;20:725-734.
21. O'Brien JA, Shomphe LA, Kavanagh PL, et al. Direct medical costs of complications resulting from type 2 diabetes in the US. Diabetes Care 1998;21:1122-1128.
22. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-797.
23. US Department of Health and Human Services. A Public Health Action Plan to Prevent Heart Disease and Stroke. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2003.
24. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden. Cancer 2002; 94:2766-2792.
25. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
26. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US: 1990-1998. Diabetes Care 2000;23:1278-1283.
27. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-1245.
28. Centers for Disease Control and Prevention, National Center for Health Statistics. Annual smoking attributable-mortality, years of potential life lost, and economic costs - United States, 1995-1999. MMWR Morb Mortal Wkly Rep 2002;51:300-303.
29. Centers for Disease Control and Prevention. Smoking-attributable mortality, morbidity, and economic costs (SAMMEC): adult SAMMEC and maternal and child health (MCH) SAMMEC software, 2002c. Available at: http://www.cdc.gov/tobacco/sammec.
30. US Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990.
31. Centers for Disease Control and Prevention, National Center for Health Statistics. Cigarette smoking attributable morbidity - United States, 2000. MMWR Morb Mortal Wkly Rep 2003; 52:842-844.
32. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-1308.
33. International Agency for Research on Cancer. Tobacco Smoke and Involuntary Smoking. Vol. 83. Lyon, France: International Agency for Research on Cancer; 2002. Available at: http://193.51.164.11/htdocs/monographs/vol83/02-involuntary.html. Accessed April 1, 2004.
34. Will JC, Galuska DA, Ford ES, et al. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol 2001;30:540-546.
35. Manson JE, Ajani UA, Liu S, et al. A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med 2000;109:538-542.
36. Rimm EB, Chan J, Stampfer MJ, et al. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 1995;310:555-559.
37. Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care 2001;24:1590-1595.
38. Kawakami N, Takatsuka N, Shimizu H, et al. Effects of smoking on the incidence of noninsulin-dependent diabetes mellitus. Replication and extension in a Japanese cohort of male employees. Am J Epidemiol 1997;145:103-109.
39. Mulhauser I, Bender R, Bott U, et al. Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes mellitus. Diabet Med 1996;13:536-543.
40. Chuahirun T, Wesson DE. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis 2002;39:376-382.
41. Mitchell BD, Hawthorne VM, Vinik AI. Cigarette smoking and neuropathy in diabetic patients. Diabetes Care 1990;13:434-437.
42. US Department of Health and Human Services. Preventing Tobacco Use Among Young People: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1994.
43. Fiore M, Bailey W, Cohen S, et al. Treating Tobacco Use and Dependence. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2000.
44. US Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2000.
45. Stillman FA, Hartman AM, Graubard BI, et al. Evaluation of the American Stop Smoking Intervention Study (ASSIST): a report of outcomes. J Natl Cancer Inst 2003;95:1681-1691.
46. Wakefield M, Chaloupka F. Effectiveness of comprehensive tobacco control programmes in reducing teenage smoking in the USA. Tob Control 2000;9:177-186.
47. Fichtenberg CM, Glantz SA. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. N Engl J Med 2000;343: 1772-1777.
48. Jemal A, Cokkinides VE, Shafey O, et al. Lung cancer trends in young adults: an early indicator of progress in tobacco control. Cancer Causes Control 2003;14:579-585.
49. Silagy C, Ketteridge S. The effectiveness of physician advice to aid smoking cessation. Database of Abstracts of Reviews of Effectiveness. The Cochrane Library, Issue 2: Oxford, United Kingdom: Update Software; 2004.
50. Curry SJ. Building effective strategies to decrease tobacco use in a health maintenance organisation: Group Health Cooperative of Puget Sound. Tob Control 1998;7(Suppl):S21-S23; discussion S24-S25.
51. Katz DA, Muehlenbruch DR, Brown RL, et al. Effectiveness of implementing the agency for healthcare research and quality smoking cessation clinical practice guideline: a randomized, controlled trial. J Natl Cancer Inst 2004;96:594-603.
52. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
53. World Health Organization. Physical status: the use and interpretation of anthropometry: report of a WHO expert committee. World Health Organ Tech Rep Set 1995;854:1-452.
54. Ogden CL, Flegal KM, Carroll MD, et al, Prevalence and trends in overweight among US chilren and adolescents, 1999-2000. JAMA 2002;288:1728-1732.
55. Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 2000;72:1074-1081.
56. National Heart, Lung, and Blood Institute. The Practical Guide: Identification, Evaluation and Treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health; 2000.
57. Sturm R. The effects of obesity, smoking, and problem drinking on chronic medical problems and health care costs. Health Aff 2002;21: 245-253.
58. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-977.
59. Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999;100: 1481-1492.
60. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997;96:3248-3250.
61. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003;115(Suppl 8A):37S-41S.
62. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003;107:1448-1453.
63. Rodriguez BL, D'Agostino R, Abbott RD, et al. Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: a comparison of incidence and risk factor effects. Stroke 2002;33:230-236.
64. Suk SH, Sacco RL, Boden-Albala B, et al. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2003;34:1586-1592.
65. Katzel LI, Bleecker ER, Rogus EM, Goldberg AP. Sequential effects of aerobic exercise training and weight loss on risk factors for coronary disease in healthy, obese middle-aged and older men. Metabolism 1997;46:1441-1447.
66. Czernichow S, Mennen L, Bertrais S, et al. Relationships between changes in weight and changes in cardiovascular risk factors in middleaged French subjects: effect of dieting. Int J Obes Relat Metab Disord 2002;26:1138-1143.
67. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002;106:388-391.
68. Wadden TA, Anderson DA, Foster GD. Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions. Obes Res 1999;7:170-178.
69. National Heart Lung and Blood Institute/North American Association for the Study of Obesity. Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health; 2000.
70. Oster G, Thompson D, Edelsberg J, et al. Lifetime health and economic benefits of weight loss among obese persons. Am J Public Health 1999;89:1536-1542.
71. Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999;341:1097-1105.
72. Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000;343:1305-1311.
73. Michaud DS, Giovannucci E, Willett WC et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001;286:921-929.
74. Feigelson HS, Jonas CR, Teras LR, et al. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2004;13:220-224.
75. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625-1638.
76. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Vol. 6. Weight control and physical activity. Lyon, France: International Agency for Research on Cancer; 2002.
77. Seidell JC. Obesity, insulin resistance and diabetes-a worldwide epidemic. Br J Nutr 2000; 83(Suppl 1):S5-S8.
78. Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003;88:1417-1427.
79. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Prevention Program meeting summary. Diabetes Mellitus Interagency Coordinating Committee. August 8, 2001. Available at: http://www.niddk.nih.gov/federal/dmicc/dppresults.pdf. Accessed April 19, 2004.
80. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
81. Sherwin RS, Anderson RM, Buse JB, et al. The prevention or delay of type 2 diabetes. Diabetes Care 2004;27(Suppl. 1):S47-S54.
82. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344. 1343-1350.
83. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group. Metabolism 1990;39:905-912.
84. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 56:320-328.
85. Williams KV, Kelley DE. Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes. Diabetes Obes Metab 2000;2:121-129.
86. Krauss RM, Eckel RH, Howard B, et al. AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102:2284-2299.
87. Byers T, Nestle M, McTiernan A, et al, American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2002;52:92-119.
88. American Cancer Society. Cancer Prevention and Early Detection Facts & Figures. Atlanta, GA: American Cancer Society; 2004.
89. Putnam J, Allshouse J, Kantor L. US per capita food supply trends: more calories, refined carbohydrates, and fats. FoodReview Vol. 25, Issue 3, Winter 2002. Available at: http://www.ers.usda.gov/publications/FoodReview/DEC2002/frvol25i3a.pdf. Accessed April 19, 2004.
90. Enns C, Goldman JD, Cook A. Trends in food and nutrient intakes by adults: NFCS 1977-1978, CSFII 1989-1991, and CSFII 1994-1995. Family Eco Nutr Rev 1997;10:2-15.
91. Centers for Disease Control and Prevention. Trends in intake of energy and macronutrients - United States, 1971-2000. MMWR Morb Mortal Wkly Rep 2004;53:80-82.
92. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science 2003;299:853-855.
93. National Cholesterol Education Program Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Bethesda, MD: National Institutes of Health; 2002. NIH Publication No. 01-3670.
94. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3-10.
95. Doll R. The lessons of life: keynote address to the nutrition and cancer conference. Cancer Res 1992;52(7 Suppl):2024s-2029s.
96. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA 1993;270: 2207-2212.
97. Willett WC. Micronutrients and cancer risk. Am J Clin Nutr 1994;59(5 Suppl):1162S-1165S.
98. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 1991;2:427-442.
99. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 1991;2:325-357.
100. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Vol. 8. Fruit and vegetables. Lyon, France: International Agency for Research on Cancer; 2003.
101. Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002;25:148-198.
102. Lee IM, Paffenbarger RS Jr, Hennekens CH. Physical activity, physical fitness and longevity. Aging (Milano) 1997;9:2-11.
103. Blair SN, Jackson AS. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc 2001;33: 762-764.
104. Powell KE, Thompson PD, Caspersen CJ, Kendrick JS. Physical activity and the incidence of coronary heart disease. Annu Rev Public Health 1987;8:253-287.
105. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001;103:163-182.
106. Fletcher GF, Balady G, Blair SN, et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1996;94:857-862.
107. Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003;107:3109-3116.
108. Fletcher GF. How to implement physical activity in primary and secondary prevention. A statement for healthcare-professionals from the Task Force on Risk-reduction, American Heart Association. Circulation 1997;96:355-357.
109. Colditz GA, Cannuscio CC, Frazier AL. Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control 1997;8:649-667.
110. Martinez ME, Giovannucci E, Spiegelman D, et al. Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst 1997;89:948-955.
111. McTiernan A, Ulrich C, Slate S, Potter J. Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control 1998;9: 487-509.
112. Friedenreich CM, Courneya KS, Bryant HE. Influence of physical activity in different age and life periods on the risk of breast cancer. Epidemiology 2001;12:604-612.
113. Friedenreich CM. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev 2001;10:287-301.
114. National Institutes of Health Consensus Development Panel. Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. Natl Inst Health Consens Dev Conf Consens Statement 1985;5: 1-7.
115. Wideroff L, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89: 1360-1365.
116. Lindblad P, Chow WH, Chan J, et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 1999;42:107-112.
117. Calle EE, Murphy TK, Rodriguez C, et al. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control 1998;9:403-410.
118. Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 1998:147:816-825.
119. Slattery ML, Edwards SL, Ma KN, et al. Physical activity and colon cancer: a public health perspective. Ann Epidemiol 1997;7: 137-145.
120. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L, Lifetime exercise activity and breast cancer risk among post-menopausal women. Br J Cancer 1999;80:1852-1858.
121. Centers for Disease Control and Prevention. State-specific trends in high blood cholesterol awareness among persons screened - United States, 1991-1999. MMWR Morb Mortal Wkly Rep 2001;50:754-758.
122. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
123. Pearson TA. New tools for coronary risk assessment: what are their advantages and limitations? Circulation 2002;105:886-892.
124. D'Agostino RB Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180-187.
125. Grundy SM, D'Agostino RB Sr, Mosca L, et al. Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood Institute workshop. Circulation 2001;104:491-496.
126. US Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002;137(5 Part 1):344-346.
127. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;53:141-169.
128. Tabar L, Yen MF, Vitak B, et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361: 1405-1410.
129. Saslow D, Runowicz C, Solomon D, et al. American Cancer Society Guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362.
130. Pignone M, Rich M, Teutsch SM, et al. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137:132-141.
131. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003;124: 544-560.
132. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75; quiz 77-80.
133. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002;51: 2796-2803.
134. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-2077.
135. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991;34: 891-898.
136. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544.
137. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000;23:381-389.
138. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27(Suppl 1):S5-SlO.
139. Troisi RJ, Cowie CC, Harris MI. Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon. JAMA 2000;284: 3157-3159.
140. Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979;121:1193-1254.
141. Frame PS. A critical review of adult health maintenance. Part 1: Prevention of atherosclerotic diseases. J Fam Pract 1986;22:341-346.
142. Frame PS. A critical review of adult health maintenance. Part 2. Prevention of infectious diseases. J Fam Pract 1986;22:417-422.
143. Frame PS. A critical review of adult health maintenance. Part 3: Prevention of cancer. J Fam Pract 1986;22:511-520.
144. Frame PS. A critical review of adult health maintenance: Part 4. Prevention of metabolic, behavioral, and miscellaneous conditions. J Fam Pract 1986;23:29-39.
145. Ruffin MT, Gorenflo DW, Woodman B. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J Am Board Fam Pract 2000;13:1-10.